Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases

Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients

(2014) Yetrib Hathout et al.   HUMAN MOLECULAR GENETICS

Metabolic quirks yield tumour hope

(2014) Heidi Ledford   NATURE

Cancer Abolishes the Tissue Type-Specific Differences in the Phenotype of Energetic Metabolism

(2014) Paloma Acebo et al.   Translational Oncology

Inhibition of ATPIF1 Ameliorates Severe Mitochondrial Respiratory Chain Dysfunction in Mammalian Cells

(2014) Walter W. Chen et al.   Cell Reports

Mitochondrial Alterations and Oxidative Stress in an Acute Transient Mouse Model of Muscle Degeneration

(2013) Renjini Ramadasan-Nair et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cellular and molecular mechanisms underlying muscular dystrophy

(2013) Fedik Rahimov et al.   JOURNAL OF CELL BIOLOGY

Exome Sequencing and Functional Validation in Zebrafish Identify GTDC2 Mutations as a Cause of Walker-Warburg Syndrome

(2012) M. Chiara Manzini et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Mitochondria-Mediated Energy Adaption in Cancer: The H+-ATP Synthase-Geared Switch of Metabolism in Human Tumors

(2012) María Sánchez-Aragó et al.   ANTIOXIDANTS & REDOX SIGNALING

Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry

(2012) Alejandro Lucia et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2

(2012) Richard J L F Lemmers et al.   NATURE GENETICS

A Transcriptomic Approach to Search for Novel Phenotypic Regulators in McArdle Disease

(2012) Gisela Nogales-Gadea et al.   PLoS One

Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers

(2012) F. Rahimov et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer

(2011) M. Aldea et al.   CANCER LETTERS

Quantitative Proteomic Analysis of Dystrophic Dog Muscle

(2011) Laetitia Guevel et al.   JOURNAL OF PROTEOME RESEARCH

The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil

(2011) María Sánchez-Aragó et al.   Journal of Translational Medicine

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)

(2011) V.D. Nadarajah et al.   NEUROMUSCULAR DISORDERS

Biochemical markers of muscular damage

(2010) Paola Brancaccio et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Up-regulation of the ATPase Inhibitory Factor 1 (IF1) of the Mitochondrial H+-ATP Synthase in Human Tumors Mediates the Metabolic Shift of Cancer Cells to a Warburg Phenotype

(2010) Laura Sánchez-Cenizo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Reverse phase protein microarrays advance to use in clinical trials

(2010) Claudius Mueller et al.   Molecular Oncology

The tumor suppressor function of mitochondria: Translation into the clinics

(2009) José M. Cuezva et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE